Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences.
Autor: | Karam, Susan L., Dendy, Jared, Polu, Shruti, Blonde, Lawrence |
---|---|
Předmět: | |
Zdroj: | Diabetes Spectrum; Feb2020, Vol. 33 Issue 1, p8-15, 8p |
Abstrakt: | Many people with diabetes do not achieve individualized treatment targets. Therapeutic inertia, the underuse of effective therapies in preventing serious clinical end points, is a frequent, important contributor to this failure. Clinicians, patients, health systems, payors, and producers of medications, devices, and other products for those with diabetes all play a role in the development of therapeutic inertia and can all help to reduce it [ABSTRACT FROM AUTHOR] |
Databáze: | Complementary Index |
Externí odkaz: |